-
Long-term Cardiopulmonary Consequences of Treatment-Induced Cardiotoxicity in Survivors of ERBB2-Positive Breast CancerAF Yu, JR Flynn, CS Moskowitz et al. -
Drug-Drug Interactions of Common Cardiac Medications and Chemotherapeutic AgentsS Zukkoor, V Thohan.
-
Randomized study of doxorubicin-based chemotherapy regimens, with and without sildenafil, with analysis of intermediate cardiac markersPoklepovic A, Qu Y, Dickinson M et al.
-
Risk of Cardiovascular Diseases Among Older Breast Cancer Survivors in the United States: A Matched Cohort StudyAA Matthews, SP Hinton, S Stanway et al.
-
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients With CancerKhorana AA, Soff GA, CASSINI Investigators.
-
Strain-Guided Management of Potentially Cardiotoxic Cancer TherapyP Thavendiranathan, T Negishi, SUCCOUR investigators et al.
-
Endoplasmic reticulum stress in doxorubicin-induced cardiotoxicity may be therapeutically targeted by natural and chemical compounds: A reviewF Yarmohammadi, R Rezaee, AW Haye et al.
-
Venous and Arterial Thromboembolism in Patients With Cancer: JACC: CardioOncology State-of-the-Art ReviewL Gervaso , H Dave , AA Khorana et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
